{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:17:03Z","timestamp":1782947823306,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49811-6","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:33:42Z","timestamp":1777556022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A-stream glaucoma shunt versus trabeculectomy: 1-year results on efficacy and safety"],"prefix":"10.1038","volume":"16","author":[{"given":"Hae Min","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Chul","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungsoo","family":"Rho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"49811_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns, J. E. Trabeculectomy. Preliminary report of a new method. Am. J. Ophthalmol. 66, 673\u2013679 (1968).","journal-title":"Am. J. Ophthalmol."},{"key":"49811_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/ICU.0000000000000236","volume":"27","author":"AK Sawchyn","year":"2016","unstructured":"Sawchyn, A. K. & Slabaugh, M. A. Innovations and adaptations in trabeculectomy. Curr. Opin. Ophthalmol. 27, 158\u2013163. https:\/\/doi.org\/10.1097\/ICU.0000000000000236 (2016).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"49811_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.ophtha.2017.05.014","volume":"124","author":"VL Tseng","year":"2017","unstructured":"Tseng, V. L. et al. Risk Factors and Long-Term Outcomes in Patients with Low Intraocular Pressure after Trabeculectomy. Ophthalmology 124, 1457\u20131465. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.014 (2017).","journal-title":"Ophthalmology"},{"key":"49811_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ajo.2012.10.017","volume":"155","author":"S Zahid","year":"2013","unstructured":"Zahid, S., Musch, D. C., Niziol, L. M. & Lichter, P. R. Collaborative Initial Glaucoma Treatment Study, G. Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am. J. Ophthalmol. 155, 674\u2013680. https:\/\/doi.org\/10.1016\/j.ajo.2012.10.017 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"49811_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/s0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter, P. R. et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108, 1943\u20131953. https:\/\/doi.org\/10.1016\/s0161-6420(01)00873-9 (2001).","journal-title":"Ophthalmology"},{"key":"49811_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","volume":"129","author":"SJ Gedde","year":"2022","unstructured":"Gedde, S. J. et al. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up. Ophthalmology 129, 1344\u20131356. https:\/\/doi.org\/10.1016\/j.ophtha.2022.07.003 (2022).","journal-title":"Ophthalmology"},{"key":"49811_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","volume":"140","author":"HD Jampel","year":"2005","unstructured":"Jampel, H. D. et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am. J. Ophthalmol. 140, 16\u201322. https:\/\/doi.org\/10.1016\/j.ajo.2005.02.013 (2005).","journal-title":"Am. J. Ophthalmol."},{"issue":"Pt 3","key":"49811_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/eye.1990.54","volume":"4","author":"PG Watson","year":"1990","unstructured":"Watson, P. G. et al. The complications of trabeculectomy (a 20-year follow-up). Eye (Lond). 4 (Pt 3), 425\u2013438. https:\/\/doi.org\/10.1038\/eye.1990.54 (1990).","journal-title":"Eye (Lond)"},{"key":"49811_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb, H. & Ahmed, I. I. Micro-invasive glaucoma surgery: Current perspectives and future directions. Curr. Opin. Ophthalmol. 23, 96\u2013104. https:\/\/doi.org\/10.1097\/ICU.0b013e32834ff1e7 (2012).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"49811_CR10","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.ophtha.2015.02.029","volume":"122","author":"J Caprioli","year":"2015","unstructured":"Caprioli, J. et al. Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology 122, 1795\u20131801. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.029 (2015).","journal-title":"Ophthalmology"},{"key":"49811_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ogla.2019.12.003","volume":"3","author":"RL Fellman","year":"2020","unstructured":"Fellman, R. L. et al. American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery. Ophthalmol. Glaucoma. 3, 1\u20136. https:\/\/doi.org\/10.1016\/j.ogla.2019.12.003 (2020).","journal-title":"Ophthalmol. Glaucoma"},{"key":"49811_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00417-016-3514-8","volume":"255","author":"J Gonnermann","year":"2017","unstructured":"Gonnermann, J. et al. Contralateral eye comparison study in MICS & MIGS: Trabectome(R) vs. iStent inject(R). Graefes Arch. Clin. Exp. Ophthalmol. 255, 359\u2013365. https:\/\/doi.org\/10.1007\/s00417-016-3514-8 (2017).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"49811_CR13","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1111\/aos.14906","volume":"100","author":"J Jablonska","year":"2022","unstructured":"Jablonska, J., Lewczuk, K., Konopinska, J., Mariak, Z. & Rekas, M. Microinvasive glaucoma surgery: a review and classification of implant-dependent procedures and techniques. Acta Ophthalmol. 100, e327\u2013e338. https:\/\/doi.org\/10.1111\/aos.14906 (2022).","journal-title":"Acta Ophthalmol."},{"key":"49811_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ophtha.2023.09.023","volume":"131","author":"JF Panarelli","year":"2024","unstructured":"Panarelli, J. F. et al. Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: two-year results from a randomized, multicenter study. Ophthalmology 131, 266\u2013276. https:\/\/doi.org\/10.1016\/j.ophtha.2023.09.023 (2024).","journal-title":"Ophthalmology"},{"key":"49811_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","volume":"257","author":"H Reitsamer","year":"2019","unstructured":"Reitsamer, H. et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 257, 983\u2013996. https:\/\/doi.org\/10.1007\/s00417-019-04251-z (2019).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"49811_CR16","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1167\/iovs.15-16625","volume":"56","author":"A Sheybani","year":"2015","unstructured":"Sheybani, A., Reitsamer, H. & Ahmed, I. I. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest. Ophthalmol. Vis. Sci. 56, 4789\u20134795. https:\/\/doi.org\/10.1167\/iovs.15-16625 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"49811_CR17","unstructured":"<\u2009JOGCP. Porosity of Bleb Capsule declines rapidly with Fluid Challenge.pdf&gt."},{"key":"49811_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41433-025-03728-y","volume":"39","author":"HM Park","year":"2025","unstructured":"Park, H. M. et al. Short-term efficacy and safety of A-stream glaucoma shunt: a 6-month study. Eye (Lond). 39, 1584\u20131591. https:\/\/doi.org\/10.1038\/s41433-025-03728-y (2025).","journal-title":"Eye (Lond)"},{"key":"49811_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajo.2023.03.026","volume":"252","author":"A Sheybani","year":"2023","unstructured":"Sheybani, A. et al. Gel Stent versus trabeculectomy: the randomized, multicenter, gold-standard pathway study (GPS) of effectiveness and safety at 12 months. Am. J. Ophthalmol. 252, 306\u2013325. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.026 (2023).","journal-title":"Am. J. Ophthalmol."},{"key":"49811_CR20","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41433-024-03042-z","volume":"38","author":"T Rauchegger","year":"2024","unstructured":"Rauchegger, T. et al. Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma. Eye (Lond). 38, 1908\u20131916. https:\/\/doi.org\/10.1038\/s41433-024-03042-z (2024).","journal-title":"Eye (Lond)"},{"key":"49811_CR21","doi-asserted-by":"publisher","first-page":"e0231614","DOI":"10.1371\/journal.pone.0231614","volume":"15","author":"FM Wagner","year":"2020","unstructured":"Wagner, F. M., Schuster, A. K., Emmerich, J., Chronopoulos, P. & Hoffmann, E. M. Efficacy and safety of XEN(R)-Implantation vs. trabeculectomy: data of a real-world setting. PLoS One 15, e0231614. https:\/\/doi.org\/10.1371\/journal.pone.0231614 (2020).","journal-title":"PLoS One"},{"key":"49811_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IJG.0000000000001394","volume":"29","author":"N Midha","year":"2020","unstructured":"Midha, N., Gillmann, K., Chaudhary, A., Mermoud, A. & Mansouri, K. Efficacy of needling revision after XEN gel stent implantation: a prospective study. J. Glaucoma 29, 11\u201314. https:\/\/doi.org\/10.1097\/IJG.0000000000001394 (2020).","journal-title":"J. Glaucoma"},{"key":"49811_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/IJG.0000000000002090","volume":"31","author":"MT Marcos-Parra","year":"2022","unstructured":"Marcos-Parra, M. T. et al. 3-year outcomes of XEN implant compared with trabeculectomy, with or without phacoemulsification for open angle glaucoma. J. Glaucoma 31, 826\u2013833. https:\/\/doi.org\/10.1097\/IJG.0000000000002090 (2022).","journal-title":"J. Glaucoma"},{"key":"49811_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ogla.2023.05.001","volume":"6","author":"IM Hussein","year":"2023","unstructured":"Hussein, I. M., De Francesco, T. & Ahmed, I. I. K. Intermediate outcomes of the novel 63-mum gelatin microstent versus the conventional 45-mum gelatin microstent. Ophthalmol. Glaucoma 6, 580\u2013591. https:\/\/doi.org\/10.1016\/j.ogla.2023.05.001 (2023).","journal-title":"Ophthalmol. Glaucoma"},{"key":"49811_CR25","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41598-024-55287-z","volume":"14","author":"JM Martinez-de-la-Casa","year":"2024","unstructured":"Martinez-de-la-Casa, J. M. et al. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma. Sci. Rep. 14, 4561. https:\/\/doi.org\/10.1038\/s41598-024-55287-z (2024).","journal-title":"Sci. Rep."},{"key":"49811_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/bjo.85.10.1231","volume":"85","author":"A team","year":"2001","unstructured":"team, A. Experimental flow studies in glaucoma drainage device development. Br. J. Ophthalmol. 85, 1231\u20131236. https:\/\/doi.org\/10.1136\/bjo.85.10.1231 (2001).","journal-title":"Br. J. Ophthalmol."},{"key":"49811_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archopht.1997.01100150188007","volume":"115","author":"AL Coleman","year":"1997","unstructured":"Coleman, A. L., Smyth, R. J., Wilson, M. R. & Tam, M. Initial clinical experience with the Ahmed Glaucoma Valve implant in pediatric patients. Arch. Ophthalmol. 115, 186\u2013191. https:\/\/doi.org\/10.1001\/archopht.1997.01100150188007 (1997).","journal-title":"Arch. Ophthalmol."},{"key":"49811_CR28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/IJG.0000000000001661","volume":"29","author":"AM Al Owaifeer","year":"2020","unstructured":"Al Owaifeer, A. M., Alobaida, I., Alrefaie, S., Malik, R. & Aljadaan, I. The effect of tube ligature on the safety and efficacy of ahmed glaucoma valve surgery. J. Glaucoma 29, 1173\u20131178. https:\/\/doi.org\/10.1097\/IJG.0000000000001661 (2020).","journal-title":"J. Glaucoma"},{"key":"49811_CR29","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/IJG.0000000000000869","volume":"27","author":"M Feinstein","year":"2018","unstructured":"Feinstein, M., Moussa, K. & Han, Y. Ab interno tube occlusion for postoperative hypotony in a patient with an ahmed glaucoma drainage device. J. Glaucoma 27, e61\u2013e63. https:\/\/doi.org\/10.1097\/IJG.0000000000000869 (2018).","journal-title":"J. Glaucoma"},{"key":"49811_CR30","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres, L. M. J. et al. XEN((R)) Gel Stent compared to PRESERFLO MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 99, e433\u2013e440. https:\/\/doi.org\/10.1111\/aos.14602 (2021).","journal-title":"Acta Ophthalmol."},{"key":"49811_CR31","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1097\/IJG.0000000000001839","volume":"30","author":"M DiSclafani","year":"2021","unstructured":"DiSclafani, M., Richards, D., Schneider, A., Whitfield, W. & Ayoubi, Y. Intraluminal stent optimization for the baerveldt glaucoma implant: an experimental study. J. Glaucoma 30, e334\u2013e337. https:\/\/doi.org\/10.1097\/IJG.0000000000001839 (2021).","journal-title":"J. Glaucoma"},{"key":"49811_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002594","author":"C Weber","year":"2025","unstructured":"Weber, C. et al. Clinical outcomes of intraluminal stent removal after PAUL(R) glaucoma implant surgery. J. Glaucoma https:\/\/doi.org\/10.1097\/IJG.0000000000002594 (2025).","journal-title":"J. Glaucoma"},{"key":"49811_CR33","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/s41598-025-87259-2","volume":"15","author":"Y Miura","year":"2025","unstructured":"Miura, Y., Fukuda, K. & Yamashiro, K. Comparison of outcomes with and without intrastent placement during PMS surgery. Sci. Rep. 15, 2981. https:\/\/doi.org\/10.1038\/s41598-025-87259-2 (2025).","journal-title":"Sci. Rep."},{"key":"49811_CR34","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s00417-024-06567-x","volume":"262","author":"R Verma-Fuehring","year":"2024","unstructured":"Verma-Fuehring, R. et al. The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony. Graefes Arch. Clin. Exp. Ophthalmol. 262, 3925\u20133932. https:\/\/doi.org\/10.1007\/s00417-024-06567-x (2024).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"49811_CR35","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12325-024-02788-y","volume":"41","author":"FH Hengerer","year":"2024","unstructured":"Hengerer, F. H., Auffarth, G. U. & Conrad-Hengerer, I. 7-year efficacy and safety of istent inject trabecular micro-bypass in combined and standalone usage. Adv. Ther. 41, 1481\u20131495. https:\/\/doi.org\/10.1007\/s12325-024-02788-y (2024).","journal-title":"Adv. Ther."},{"key":"49811_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00417-024-06649-w","volume":"263","author":"L Governatori","year":"2025","unstructured":"Governatori, L. et al. PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic review. Graefes Arch. Clin. Exp. Ophthalmol. 263, 885\u2013899. https:\/\/doi.org\/10.1007\/s00417-024-06649-w (2025).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"49811_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ogla.2022.11.006","volume":"6","author":"L Van Lancker","year":"2023","unstructured":"Van Lancker, L. et al. Clinical outcomes and cost analysis of preserflo versus trabeculectomy for glaucoma management in the United Kingdom. Ophthalmol. Glaucoma 6, 342\u2013357. https:\/\/doi.org\/10.1016\/j.ogla.2022.11.006 (2023).","journal-title":"Ophthalmol. Glaucoma"},{"key":"49811_CR38","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archopht.125.8.1044","volume":"125","author":"SK Law","year":"2007","unstructured":"Law, S. K., Nguyen, A. M., Coleman, A. L. & Caprioli, J. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch. Ophthalmol. 125, 1044\u20131050. https:\/\/doi.org\/10.1001\/archopht.125.8.1044 (2007).","journal-title":"Arch. Ophthalmol."},{"key":"49811_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11185481","author":"MX Fu","year":"2022","unstructured":"Fu, M. X. et al. MicroShunt versus trabeculectomy for surgical management of glaucoma: a retrospective analysis. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11185481 (2022).","journal-title":"J. Clin. Med."},{"key":"49811_CR40","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1111\/aos.16658","volume":"102","author":"A Khan","year":"2024","unstructured":"Khan, A. & Khan, A. U. Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. Acta Ophthalmol. 102, e443\u2013e451. https:\/\/doi.org\/10.1111\/aos.16658 (2024).","journal-title":"Acta Ophthalmol."},{"key":"49811_CR41","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1038\/s41598-025-92879-9","volume":"15","author":"H Mieno","year":"2025","unstructured":"Mieno, H. et al. Risk factors and protective strategies for hypotony following preserflo microshunt implantation. Sci. Rep. 15, 8344. https:\/\/doi.org\/10.1038\/s41598-025-92879-9 (2025).","journal-title":"Sci. Rep."},{"key":"49811_CR42","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s10792-022-02342-1","volume":"42","author":"NY Ercalik","year":"2022","unstructured":"Ercalik, N. Y., Tekcan, H., Mangan, M. S., Ozcelik Kose, A. & Imamoglu, S. Analysis of risk factors and ocular hypotony characteristics in choroidal detachment after penetrating glaucoma surgery. Int. Ophthalmol. 42, 3431\u20133440. https:\/\/doi.org\/10.1007\/s10792-022-02342-1 (2022).","journal-title":"Int. Ophthalmol."},{"key":"49811_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03843-w","author":"T Theilig","year":"2025","unstructured":"Theilig, T., Papadimitriou, M., Meller, D. & Hasan, S. M. PRESERFLO MicroShunt as a treatment option for highly increased intraocular pressure in primary open angle glaucoma and pseudoexfoliation glaucoma. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-025-03843-w (2025).","journal-title":"Eye (Lond)"},{"key":"49811_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers, H. J. M. et al. Safety and effectiveness of the PRESERFLO(R) microshunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol. Glaucoma 5, 195\u2013209. https:\/\/doi.org\/10.1016\/j.ogla.2021.07.008 (2022).","journal-title":"Ophthalmol. Glaucoma"},{"key":"49811_CR45","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","volume":"37","author":"R Bhayani","year":"2023","unstructured":"Bhayani, R. et al. Short-term safety and efficacy of Preserflo Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond). 37, 644\u2013649. https:\/\/doi.org\/10.1038\/s41433-022-01995-7 (2023).","journal-title":"Eye (Lond)"},{"key":"49811_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41433-023-02642-5","volume":"38","author":"F Oddone","year":"2024","unstructured":"Oddone, F. et al. Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry. Eye (Lond). 38, 103\u2013111. https:\/\/doi.org\/10.1038\/s41433-023-02642-5 (2024).","journal-title":"Eye (Lond)"},{"key":"49811_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","volume":"129","author":"IIK Ahmed","year":"2022","unstructured":"Ahmed, I. I. K. et al. Long-term outcomes from the HORIZON randomized trial for a schlemm\u2019s canal microstent in combination cataract and glaucoma surgery. Ophthalmology 129, 742\u2013751. https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.021 (2022).","journal-title":"Ophthalmology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49811-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:34:33Z","timestamp":1782945273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49811-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jong Chul Han is the founder of MICROT Inc. (Seoul, Republic of Korea), which manufactures the A-stream Glaucoma Shunt. This potential conflict of interest has been disclosed to the journal, and all efforts were made to ensure that the study results are presented objectively. None of the other authors has any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20169"}}